Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02140775 · ClinicalTrials.gov registry record · NA

Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDS

A NA study, sponsored by New York State Psychiatric Institute.

Completed
Registry status
NA
Development phase
138
Enrollment target

NCT02140775 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 138 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02140775, a NA study, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
NA
Development phase
138 participants
Enrollment target

Study Summary

The current study is a randomized clinical trial comparing Behavioral Activation counseling with supportive counseling for HIV+ participants presenting with clinically significant fatigue whose energy has improved with armodafinil, who have the goal of returning to work or vocational training but have not done so on their own. A second cohort of HIV+ participants without significant fatigue at baseline, but who also have the goal of returning to work, will also be randomized to either Behavioral Activation counseling or supportive counseling. In both cohorts, the primary outcome is level of success regarding an employment related goal.

Interventions

  • BEHAVIORAL Behavioral Activation Counseling

Trial Details

FieldValue
Enrollment Target 138 participants
Start Date 2014-04-01
Est. Completion 2019-05-31
Phase NA

What the Registry Record Tells You About NCT02140775

The ClinicalTrials.gov registry entry for NCT02140775 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Behavioral Activation Counseling is the first listed.

NCT02140775 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02140775 about?

NCT02140775 is a clinical study titled "Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDS". The current study is a randomized clinical trial comparing Behavioral Activation counseling with supportive counseling for HIV+ participants presenting with clinically significant fatigue whose energy has improved with armodafinil, who have the goal of returning to work or vocational training but ha...

What is the current status of trial NCT02140775?

This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2014-04-01. Estimated completion is 2019-05-31.

What interventions are being tested in trial NCT02140775?

The interventions under investigation include: Behavioral Activation Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT02140775?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.